26.12.2012 Views

Transocean Proxy Statement and 2010 Annual Report

Transocean Proxy Statement and 2010 Annual Report

Transocean Proxy Statement and 2010 Annual Report

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

TRANSOCEAN LTD. AND SUBSIDIARIES<br />

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — Continued<br />

ESPP—Through December 31, 2008, we offered an ESPP under which certain full-time employees could choose to have<br />

between two <strong>and</strong> 20 percent of their annual base earnings withheld to purchase up to $21,150 of our shares each year. The purchase<br />

price of the shares was 85 percent of the lower of the beginning-of-year or end-of-year market price of our shares. At December 31, 2008,<br />

577,537 shares were available for issuance under the ESPP. As of January 1, 2009, we discontinued offering the ESPP.<br />

Note 18—Supplemental Balance Sheet Information<br />

Other current liabilities were comprised of the following (in millions):<br />

AR-113<br />

December 31,<br />

<strong>2010</strong> 2009<br />

Other current liabilities<br />

Accrued payroll <strong>and</strong> employee benefits $ 272 $ 263<br />

Deferred revenue 150 147<br />

Accrued taxes, other than income 123 102<br />

Accrued interest 97 83<br />

Unearned income 15 15<br />

Other 204 120<br />

Total other current liabilities $ 861 $ 730<br />

Other long-term liabilities were comprised of the following (in millions):<br />

December 31,<br />

<strong>2010</strong> 2009<br />

Other long-term liabilities<br />

Long-term income taxes payable $ 655 $ 594<br />

Accrued pension liabilities 416 453<br />

Deferred revenue 393 214<br />

Drilling contract intangibles 152 268<br />

Accrued retiree life insurance <strong>and</strong> medical benefits 53 51<br />

Other 103 104<br />

Total other long-term liabilities $ 1,772 $ 1,684<br />

Note 19—Fair Value of Financial Instruments<br />

We estimate the fair value of each class of financial instruments, for which estimating fair value is practicable, by applying the<br />

following methods <strong>and</strong> assumptions:<br />

Cash <strong>and</strong> cash equivalents—The carrying amount of cash <strong>and</strong> cash equivalents, which are stated at cost plus accrued interest,<br />

approximates fair value because of the short maturities of those instruments.<br />

Accounts receivable—The carrying amount, net of valuation allowance, approximates fair value because of the short maturities<br />

of those instruments.<br />

Short-term investments—The carrying amount of our short-term investments approximates fair value <strong>and</strong> represents our<br />

estimate of the amount we expect to recover. Our short-term investments primarily include our investment in The Reserve International<br />

Liquidity Fund Ltd. At December 31, <strong>2010</strong>, we did not hold any short-term investments. At December 31, 2009, the carrying amount of our<br />

short-term investments was $38 million, recorded in other current assets on our consolidated balance sheets (see Note 21—Supplemental<br />

Cash Flow Information).<br />

Notes receivable <strong>and</strong> working capital loan receivable—The carrying amount represents the estimated fair value, measured<br />

using unobservable inputs that require significant judgment, for which there is little or no market data, including the credit rating of the<br />

borrower. At December 31, <strong>2010</strong>, the aggregate carrying amount of our notes receivable <strong>and</strong> working capital loan receivable was<br />

$115 million, including $4 million <strong>and</strong> $111 million recorded in other current assets <strong>and</strong> other assets, respectively. We did not hold notes<br />

receivable as of December 31, 2009.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!